Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Webinar: High quality laboratory testing to transform the response to the global pandemic

A look at Beckman Coulter's complete testing menu for COVID-19 which includes an option for mass-antigen testing.

COVID-19 testing is critical to diagnose individuals who may spread the diseases as well as to create strategies that may aid to prevent further spread of SARS-CoV-2. There are two types of COVID-19 tests — those that are designed to detect whether a patient has an acute infection (diagnostic tests), and those intended to detect antibodies (surveillance tests).

In this webinar, you can learn more about Beckman Coulter’s High-Quality Laboratory Tests that are intended to deliver accurate and reliable results that clinicians can trust.

Learning objectives

  • Clinical utility of serology vs antigen testing
  • Barriers to mass testing
  • Low-touch testing
  • Confidence in results
  • Impact of mutations to current testing options


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Webinars On Demand

Webinars covering everything from patient safety and diagnostics during COVID-19 to business leadership and healthcare transformation, all available to watch for free on demand. 

Hear from industry leaders like Roche Diagnostics Middle East and Beckman Coulter - or catch up on the wide range of clinical content sessions from the recent Omnia Health Live.